These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 32803850

  • 1. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
    Eastburg L, Peckham A, Kawira E, Chirangi B, Adler D, Akungo BD, Smart LR, Ambrose EE.
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
    [Abstract] [Full Text] [Related]

  • 2. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C, Sinski A, Asibey J, Hardy-Dessources MD, Elana G, Brennan C, Odame I, Hoppe C, Geisberg M, Serrao E, Quinn CT.
    Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
    [Abstract] [Full Text] [Related]

  • 3. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA, Hustace T, Voltaire M, Mantero A, Liberus U, Saint Fleur R.
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [Abstract] [Full Text] [Related]

  • 4. Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Adegoke SA, Makalo L, Sallah A, Saine H, Joof S, Conteh A, Bah R, Camara Jammeh AF, Bass M, Jallow M, Nnodu OE.
    Hemoglobin; 2024 May; 48(3):169-174. PubMed ID: 38980121
    [Abstract] [Full Text] [Related]

  • 5. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
    Mano RM, Kuona P, Misihairabgwi JM.
    BMC Pediatr; 2024 May 10; 24(1):323. PubMed ID: 38730340
    [Abstract] [Full Text] [Related]

  • 6. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB, Awad S, Happich M, Muckenthaler L, Lindner M, Gramer G, Okun JG, Hoffmann GF, Bruckner T, Muckenthaler MU, Kulozik AE.
    Ann Hematol; 2016 Feb 10; 95(3):397-402. PubMed ID: 26658910
    [Abstract] [Full Text] [Related]

  • 7. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S, Mtei L, Soka D, Mdai V, Mwakale PB, Mrosso P, Mchoropa I, Rwezaula S, Azayo M, Ulenga N, Ngido M, Cox SE, D'Mello BS, Masanja H, Kabadi GS, Mbuya F, Mmbando B, Daniel Y, Streetly A, Killewo J, Tluway F, Lyimo M, Makani J.
    Int Health; 2019 Nov 13; 11(6):589-595. PubMed ID: 31145786
    [Abstract] [Full Text] [Related]

  • 8. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S.
    Int J Lab Hematol; 2022 Oct 13; 44(5):959-965. PubMed ID: 35775883
    [Abstract] [Full Text] [Related]

  • 9. Newborn Screening and Clinical Profile of Children With Sickle Cell Disease in a Tribal Area of Gujarat.
    Dave K, Desai S, Italia Y, Mukherjee MB, Mehta P, Desai G.
    Indian Pediatr; 2022 Mar 15; 59(3):230-233. PubMed ID: 35014619
    [Abstract] [Full Text] [Related]

  • 10. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE, Sopekan A, Nnebe-Agumadu U, Ohiaeri C, Adeniran A, Shedul G, Isa HA, Owolabi O, Chianumba RI, Tanko Y, Iyobosa JH, Adekile AD, Olopade OI, Piel FB.
    Lancet Haematol; 2020 Jul 15; 7(7):e534-e540. PubMed ID: 32589979
    [Abstract] [Full Text] [Related]

  • 11. Trends in sickle cell trait and disease screening in the Republic of Uganda, 2014-2019.
    Hernandez AG, Kiyaga C, Howard TA, Ssewanyana I, Ndeezi G, Aceng JR, Ware RE.
    Trop Med Int Health; 2021 Jan 15; 26(1):23-32. PubMed ID: 33151598
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening.
    Burnham-Marusich AR, Ezeanolue CO, Obiefune MC, Yang W, Osuji A, Ogidi AG, Hunt AT, Patel D, Ezeanolue EE.
    Public Health Genomics; 2016 Jan 15; 19(5):298-306. PubMed ID: 27614873
    [Abstract] [Full Text] [Related]

  • 13. Community based screening for sickle haemoglobin among pregnant women in Benue State, Nigeria: I-Care-to-Know, a Healthy Beginning Initiative.
    Ezenwosu OU, Itanyi IU, Nnodu OE, Ogidi AG, Mgbeahurike F, Ezeanolue EE.
    BMC Pregnancy Childbirth; 2021 Jul 08; 21(1):498. PubMed ID: 34238241
    [Abstract] [Full Text] [Related]

  • 14. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R, Martella M, Cattaneo L, Viola G, Cappellari A, Bergamo C, Azzena S, Schiavon S, Baraldi E, Dalla Barba B, Trafojer U, Corti P, Uggeri M, Tagliabue PE, Zorloni C, Bracchi M, Biondi A, Basso G, Masera N, Sainati L.
    Pediatr Blood Cancer; 2019 May 08; 66(5):e27657. PubMed ID: 30724025
    [Abstract] [Full Text] [Related]

  • 15. Surveillance for sickle cell disease, United Republic of Tanzania.
    Ambrose EE, Smart LR, Charles M, Hernandez AG, Latham T, Hokororo A, Beyanga M, Howard TA, Kamugisha E, McElhinney KE, Tebuka E, Ware RE.
    Bull World Health Organ; 2020 Dec 01; 98(12):859-868. PubMed ID: 33293746
    [Abstract] [Full Text] [Related]

  • 16. Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation.
    Núñez-Jurado D, Payán-Pernía S, Álvarez-Ríos AI, Jiménez-Jambrina M, Concepcion Pérez-De-Soto I, José Palma-Vallellano A, Zapata-Bautista R, Carlos Hernández-Castellet J, Paz Garrastazul-Sánchez M, Arqueros-Martínez V, Urbano-Ramos MDM, Abdelkader-Maanan M, Raúl García-Lozano J, Delgado-Pecellín C.
    Am J Perinatol; 2024 May 01; 41(S 01):e893-e900. PubMed ID: 36580977
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and factors associated with renal dysfunction among children with sickle cell disease attending the sickle cell disease clinic at a tertiary hospital in Northwestern Tanzania.
    Kimaro FD, Jumanne S, Sindato EM, Kayange N, Chami N.
    PLoS One; 2019 May 01; 14(6):e0218024. PubMed ID: 31211789
    [Abstract] [Full Text] [Related]

  • 18. The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology.
    Green NS, Zapfel A, Nnodu OE, Franklin P, Tubman VN, Chirande L, Kiyaga C, Chunda-Liyoka C, Awuonda B, Ohene-Frempong K, Inusa BPD, Ware RE, Odame I, Ambrose EE, Dogara LG, Oron AP, Willett C, Thompson AA, Berliner N, Coetzer TL, Novelli EM.
    Blood Adv; 2022 Dec 27; 6(24):6187-6197. PubMed ID: 36264096
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.